Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 98.42M | 99.01M | 95.58M | 90.63M | 84.19M | 78.01M |
Gross Profit | 78.29M | 93.53M | 90.25M | 85.53M | 79.78M | 73.87M |
EBITDA | 74.92M | 70.49M | 60.15M | 58.41M | 58.14M | 53.29M |
Net Income | 18.71M | 19.23M | 15.40M | 21.10M | 109.17M | 19.45M |
Balance Sheet | ||||||
Total Assets | 573.48M | 580.86M | 596.37M | 607.54M | 598.42M | 494.01M |
Cash, Cash Equivalents and Short-Term Investments | 6.97M | 7.10M | 8.21M | 7.61M | 22.50M | 5.74M |
Total Debt | 379.44M | 379.17M | 370.41M | 354.28M | 340.26M | 304.01M |
Total Liabilities | 401.32M | 401.32M | 395.44M | 378.44M | 363.09M | 335.00M |
Stockholders Equity | 172.17M | 179.54M | 200.93M | 229.10M | 235.33M | 159.00M |
Cash Flow | ||||||
Free Cash Flow | 45.77M | 46.91M | 35.32M | 33.19M | 34.74M | 41.94M |
Operating Cash Flow | 45.77M | 46.91M | 42.94M | 46.80M | 47.73M | 44.21M |
Investing Cash Flow | -6.83M | -13.88M | -19.11M | -36.67M | -24.43M | -27.21M |
Financing Cash Flow | -40.73M | -34.15M | -23.23M | -25.02M | -6.54M | -17.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $480.04M | ― | -1.67% | 11.02% | 1.33% | -149.80% | |
69 Neutral | $565.56M | 30.21 | 10.15% | 7.25% | 0.95% | 15.07% | |
68 Neutral | $916.75M | ― | -13.96% | 1.07% | 5.33% | 10.68% | |
67 Neutral | $127.31M | 17.36 | 36.40% | 5.47% | 22.41% | 37.88% | |
66 Neutral | $1.31B | 37.32 | 2.46% | 6.75% | -2.94% | 46.24% | |
59 Neutral | C$1.25B | -1.14 | -8.19% | 4.99% | 10.83% | -22.67% | |
58 Neutral | $517.23M | 227.80 | 1.45% | 8.41% | -1.66% | -86.24% |
On June 11, 2025, Universal Health Realty Income Trust, a company involved in real estate investment, held its Annual Meeting of Stockholders virtually. During the meeting, stockholders elected three Class III members to the Board of Trustees, approved a nonbinding advisory vote on executive compensation, and ratified KPMG, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Additionally, the company granted long-term incentive awards in the form of restricted stock to its executive officers, with vesting scheduled for two years later, reflecting a continued focus on aligning executive compensation with long-term company performance.